| HANSOH PHARMACEUTICAL GROUP |
| China |
| Gesundheit |
| KYG549581067 / A2PLRC |
| 3KY (Frankfurt) |
| FRA:3KY, ETR:3KY, 3KY:GR |
| - |
| https://www.hansoh.cn/en/ |
|
Hansoh Pharmaceutical Group Co., Ltd. is a leading biopharmaceutical company that primarily specializes in the research, development, manufacturing, and sale of innovative therapeutics. The company focuses on addressing unmet medical needs in areas s..
>Volltext.. |
| 21875.07 Mio. EUR |
| 18049.04 Mio. EUR |
| 1837.42 Mio. EUR |
| 709.17 Mio. EUR |
| 678.33 Mio. EUR |
| 0.11 EUR |
| 13.2 Mio. EUR |
| 428.03 Mio. EUR |
| 980.92 Mio. EUR |
| 7.18 |
| 7.89% |
| 11.72% |
| 0.05 EUR |
| 1.14% |
| 1.36% |
| 03.07.26 - 0.022288€ 22.09.25 - 0.025577905€ >weitere anzeigen... |
| - |
| HANSOH |
| 27.07.26 |
|
||||
|
||||
|